title: Safety of drugs used in the treatment of osteoporosis.
abstract: A number of drug classes are licensed for the treatment of osteoporosis including bisphosphonates, recombinant human parathyroid hormone (PTH), strontium, hormone replacement therapy (HRT), selective oestrogen receptor modulators (SERMS) and denosumab. This review discusses the safety of osteoporosis treatments and their efficacies. Recent concerns about the safety of calcium and high-dose vitamin D are discussed. Bisphosphonates have substantial postmarketing experience and a clearer picture of safety issues is emerging. Along with the well recognized effects on the gastrointestinal tract and kidney function, recently described adverse effects such as osteonecrosis of the jaw, oesophageal cancer, atrial fibrillation, subtrochanteric femur fractures and ocular complications of bisphosphonate therapy are discussed. Therapy with PTH is limited to two years' duration because of the development of osteogenic sarcomas in animal studies, which appeared related to dose, duration and timing of therapy. Strontium should be used with caution in patients with renal impairment and its use has been associated with venous thromboembolism. The role of HRT and SERMs in the treatment of postmenopausal osteoporosis is restricted as a result of an increased risk of stroke, venous thromboembolism and breast cancer. Postmarketing experience with denusomab is limited but a number of potential safety concerns including osteonecrosis of the jaw are emerging. All of these drugs have been proven to reduce fractures. The decision to use a drug to reduce fracture risk should be based on risk-benefit analysis of the drug and its suitability for individual patients.
authors.affiliation: Department of Medicine for the Elderly, RCSI and Beaumont Hospital, Dublin 9, Ireland.
authors.forename: Cora
authors.initials: C
authors.lastname: McGreevy
authors.affiliation: Department of Medicine for the Elderly, RCSI and Beaumont Hospital, Dublin, Ireland.
authors.forename: David
authors.initials: D
authors.lastname: Williams
keywords: adverse effects; bisphosphonates; drug safety; osteoporosis; recombinant human parathyroid hormone; strontium; vitamin D
references.citation: J Clin Endocrinol Metab. 2002 Aug;87(8):3609-17
references.pmid: 12161484
references.citation: BMJ. 2004 Feb 7;328(7435):335-6
references.pmid: 14764499
references.citation: Endocr Rev. 2002 Aug;23(4):529-39
references.pmid: 12202468
references.citation: J Bone Miner Res. 2010 Nov;25(11):2267-94
references.pmid: 20842676
references.citation: Br J Oral Maxillofac Surg. 2010 Apr;48(3):221-3
references.pmid: 19836866
references.citation: J Bone Miner Res. 1999 Jul;14(7):1217-21
references.pmid: 10404024
references.citation: J Bone Miner Res. 2007 Apr;22(4):503-8
references.pmid: 17243862
references.citation: Lancet. 2007 Aug 25;370(9588):657-66
references.pmid: 17720017
references.citation: Nat Med. 1996 Oct;2(10):1132-6
references.pmid: 8837613
references.citation: Am J Ophthalmol. 1994 Aug 15;118(2):220-4
references.pmid: 8053468
references.citation: Kidney Int. 2003 Jul;64(1):281-9
references.pmid: 12787420
references.citation: Osteoporos Int. 1999;9(5):461-8
references.pmid: 10550467
references.citation: N Engl J Med. 2008 Mar 20;358(12):1304-6
references.pmid: 18354114
references.citation: N Z Med J. 2006 Dec 01;119(1246):U2339
references.pmid: 17151713
references.citation: JAMA. 2002 Aug 21;288(7):872-81
references.pmid: 12186605
references.citation: Am J Clin Nutr. 2010 Jan;91(1):131-9
references.pmid: 19906800
references.citation: Arch Intern Med. 2009 Mar 23;169(6):551-61
references.pmid: 19307517
references.citation: J Clin Endocrinol Metab. 2010 Apr;95(4):1555-65
references.pmid: 20173017
references.citation: JAMA. 1999 Aug 18;282(7):637-45
references.pmid: 10517716
references.citation: J Clin Endocrinol Metab. 2005 Mar;90(3):1294-301
references.pmid: 15598694
references.citation: J Bone Miner Res. 2000 Apr;15(4):721-39
references.pmid: 10780864
references.citation: N Engl J Med. 2009 Jan 1;360(1):89-90
references.pmid: 19118315
references.citation: Osteoporos Int. 2008 Dec;19(12):1811-2
references.pmid: 18807101
references.citation: N Engl J Med. 2007 May 3;356(18):1809-22
references.pmid: 17476007
references.citation: J Bone Miner Res. 2009 Jun;24(6):1095-102
references.pmid: 19113931
references.citation: Ann N Y Acad Sci. 2006 Apr;1068:173-9
references.pmid: 16831916
references.citation: J Bone Miner Res. 2004 Aug;19(8):1241-9
references.pmid: 15231010
references.citation: Science. 1989 Aug 25;245(4920):855-7
references.pmid: 2528207
references.citation: Osteoporos Int. 2006;17(5):656-63
references.pmid: 16508700
references.citation: Am J Kidney Dis. 2004 Mar;43(3):566-71
references.pmid: 14981616
references.citation: J Bone Miner Res. 2005 Dec;20(12):2105-15
references.pmid: 16294264
references.citation: BMJ. 2003 Mar 1;326(7387):469
references.pmid: 12609940
references.citation: Endocr Dev. 2009;16:170-90
references.pmid: 19494667
references.citation: JAMA. 2002 Jul 17;288(3):321-33
references.pmid: 12117397
references.citation: N Engl J Med. 2002 Feb 28;346(9):653-61
references.pmid: 11870242
references.citation: Am J Health Syst Pharm. 2010 Jun 15;67(12):994-1001
references.pmid: 20516469
references.citation: N Engl J Med. 1980 Nov 20;303(21):1195-8
references.pmid: 7421945
references.citation: JAMA. 2003 Oct 1;290(13):1729-38
references.pmid: 14519707
references.citation: Clin Oral Investig. 2010 Feb;14(1):59-64
references.pmid: 19495814
references.citation: Best Pract Res Clin Rheumatol. 2007 Feb;21(1):109-22
references.pmid: 17350547
references.citation: J Bone Miner Res. 2008 Dec;23(12):1923-34
references.pmid: 18665787
references.citation: BMJ. 2010 Sep 01;341:c4506
references.pmid: 20813821
references.citation: Bone. 2010 Oct;47(4):729-35
references.pmid: 20601292
references.citation: JAMA. 2004 Apr 14;291(14):1701-12
references.pmid: 15082697
references.citation: N Engl J Med. 2009 Aug 20;361(8):756-65
references.pmid: 19671655
references.citation: Osteoporos Int. 2010 Jul;21(7):1151-4
references.pmid: 20422154
references.citation: Rev Endocr Metab Disord. 2006 Jun;7(1-2):101-12
references.pmid: 17043761
references.citation: Kidney Int. 2008 Sep;74(5):641-8
references.pmid: 18509324
references.citation: Kidney Int. 2008 Dec;74(11):1385-93
references.pmid: 18685574
references.citation: Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3597-602
references.pmid: 9520411
references.citation: JAMA. 2010 Aug 11;304(6):657-63
references.pmid: 20699457
references.citation: BMJ. 2010 Jul 29;341:c3691
references.pmid: 20671013
references.citation: Osteoporos Int. 2004 Oct;15(10):792-8
references.pmid: 15071723
references.citation: Endocr Rev. 2002 Aug;23(4):517-23
references.pmid: 12202466
references.citation: Ann Intern Med. 2007 Mar 6;146(5):326-39
references.pmid: 17339618
references.citation: J Bone Miner Res. 2005 Jan;20(1):141-51
references.pmid: 15619680
references.citation: BMJ. 2010 Sep 01;341:c4444
references.pmid: 20813820
references.citation: Am J Ophthalmol. 2003 Feb;135(2):219-22
references.pmid: 12566027
references.citation: Lancet. 1996 Dec 7;348(9041):1535-41
references.pmid: 8950879
references.citation: BMJ. 2010 Jan 12;340:b5463
references.pmid: 20068257
references.citation: JAMA. 1998 Dec 23-30;280(24):2077-82
references.pmid: 9875874
references.citation: N Engl J Med. 2007 Nov 1;357(18):1799-809
references.pmid: 17878149
references.citation: Bull Math Biol. 2000 Jan;62(1):163-88
references.pmid: 10824426
references.citation: Cochrane Database Syst Rev. 2006 Jul 19;(3):CD005326
references.pmid: 16856092
references.citation: N Engl J Med. 2003 Mar 20;348(12):1187-8
references.pmid: 12646685
references.citation: N Engl J Med. 2006 May 25;354(21):2250-61
references.pmid: 16723616
references.citation: Drugs Aging. 2010 Sep 1;27(9):771-3
references.pmid: 20809666
references.citation: BMJ. 2010 Jul 29;341:c3856
references.pmid: 20671014
references.citation: Ann Intern Med. 2006 May 16;144(10):753-61
references.pmid: 16702591
references.citation: Bone. 2010 Apr;46(4):1038-42
references.pmid: 20026265
references.citation: JAMA. 2010 May 12;303(18):1815-22
references.pmid: 20460620